Clinerion partners with Wefight to optimize patient recruitment in clinical trials by leveraging artificial intelligence to identify eligible patients from Vik community

Share Article

Clinerion’s Patient Network Explorer platform allows clinical trial sponsors to identify cohorts of patients eligible for recruitment from its global network of partner hospitals. Wefight’s Vik app brings appropriate support to patients throughout the patient journey. The collaboration will bring Vik’s patients a view on clinical studies they are eligible for.

Wefight’s Vik is a virtual companion supporting patients through their healthcare pathway. Vik brings patients appropriate support at the right time and engages patients over the long run. The app provides consented patients with a platform to gather information about their disease. Through partnership with Clinerion, Vik will now also leverage both retrospective data at the hospital level and direct-to-patient prospective data to identify, engage and recruit patients to participate in the most appropriate clinical trials, according to the trials’ protocol criteria.

Clinerion’s Patient Network Explorer helps sponsors match their trial protocols to live patient populations in Clinerion’s international network of partner hospitals. Through partnership with Wefight, the platform now also powers patient-centered recruitment.

“Many patients from our community are asking Vik, our virtual companion, to suggest the most appropriate trial they could participate in,” says Julien Moussalli, Head of Business Development of Wefight. “Patients are willing to participate in research; our role is to make the process easier. Clinical trials should no longer fail because of unmet patient recruitment timelines.”

“Clinerion is dedicated to improving patient health and outcomes by leveraging real-world data from its network of hospital partners,” says Ian Rentsch, CEO of Clinerion. “Partnership with Wefight gives additional options to patients and their treating physicians for the very best in patient care.”

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: http://www.clinerion.com
Clinerion’s Patient Network Explorer: http://www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer

For more information, please contact:
Le Vin Chin
Director, Head of Marketing & Communications
Clinerion Ltd
Elisabethenanlage 11, 4051 Basel, Switzerland
Tel.: +41 61 865 60 54
media@clinerion.com

About Wefight

Wefight is a digital health company that improves personalized patient care for better management of patients with cancer and chronic diseases. Wefight and its team of developers, engineers and data scientists develop Vik, an always improving AI-powered virtual companion supporting patients through their healthcare pathway. Vik is the fastest growing virtual patient network aiming at supporting millions of patients. Vik collects real-world data and generates real-world evidence to enhance patient care. Vik is already supporting tens of thousands of patients in five different indications.
Wefight website: http://www.wefight.co

For more information, please contact:
Julien Moussalli
Head of Business Development
Wefight
Cap Oméga, Business Innovation Center, Rond-Point Benjamin Franklin,
34000 Montpellier, France
Tel.: +33633665977
julien.moussalli@wefight.co

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Le Vin Chin
@Clinerion
Follow >
Follow us on
Visit website